Agios Pharmaceuticals Inc (AGIO)
Stock-Based Compensation
$15.94M
Quarterly · Period ending: · USD
AGIO Stock-Based Compensation
Latest reported$15.94Mperiod ending
Latest reported$15.94Mperiod ending
AGIO Quarterly Stock-Based Comp ($98.00K → $15.94M)
Quarterly stock-based compensation
High-resolution chart · PNG
AGIO stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 15,941,000 | |
| 15,541,000 | |
| 14,124,000 | |
| 12,377,000 | |
| 14,692,000 | |
| 11,359,000 | |
| 10,903,000 | |
| 11,145,000 | |
| 11,565,000 | |
| 9,234,000 | |
| 13,814,000 | |
| 9,076,000 | |
| 11,737,000 | |
| 10,139,000 | |
| 11,465,000 | |
| 11,156,000 | |
| 11,165,000 | |
| 15,510,000 | |
| 11,621,000 | |
| 12,148,000 | |
| 14,885,000 | |
| 14,854,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 18,588,000 | |
| 18,547,000 | |
| 18,108,000 | |
| 18,187,000 | |
| 24,193,000 | |
| 16,455,000 | |
| 14,522,000 | |
| 12,681,000 | |
| 12,207,000 | |
| 12,187,000 | |
| 10,734,000 | |
| 9,840,000 | |
| 12,143,000 | |
| 10,996,000 | |
| 9,107,000 | |
| 9,353,000 | |
| 9,373,000 | |
| 8,177,000 | |
| 5,060,000 | |
| 4,728,000 | |
| 2,892,000 | |
| 2,381,000 | |
| 1,505,000 | |
| 1,165,000 | |
| 1,112,000 | |
| 329,000 | |
| 424,000 | |
| 383,000 | |
| 170,000 | |
| 91,000 | |
| 98,000 |